The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Ezetimibe is a drug that lowers plasma cholesterol levels. It acts by decreasing cholesterol absorption in the small intestine. It may be used alone (marketed as Zetia or Ezetrol), when other cholesterol-lowering medications are not tolerated, or together with statins (e.g., ezetimibe/simvastatin, marketed as Vytorin or Inegy) when statins alone do not control cholesterol.
The global Ezetimibe market was valued at US$ 315 million in 2023 and is anticipated to reach US$ 460.8 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
North American market for Ezetimibe is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ezetimibe is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ezetimibe include Merck, Teva, Zydus Pharmaceuticals, Amneal Pharmaceuticals, Alkem Laboratories, APOTEX, Sandoz, Glenmark Pharmaceuticals and Mylan Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ezetimibe, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ezetimibe.
Report Scope
The Ezetimibe market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ezetimibe market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ezetimibe manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Teva
Zydus Pharmaceuticals
Amneal Pharmaceuticals
Alkem Laboratories
APOTEX
Sandoz
Glenmark Pharmaceuticals
Mylan Pharmaceuticals
Aurobindo Pharma
Accord Healthcare
Segment by Type
5mg
10mg
20mg
40mg
80mg
Segment by Application
Adult
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ezetimibe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ezetimibe in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Ezetimibe is a drug that lowers plasma cholesterol levels. It acts by decreasing cholesterol absorption in the small intestine. It may be used alone (marketed as Zetia or Ezetrol), when other cholesterol-lowering medications are not tolerated, or together with statins (e.g., ezetimibe/simvastatin, marketed as Vytorin or Inegy) when statins alone do not control cholesterol.
The global Ezetimibe market was valued at US$ 315 million in 2023 and is anticipated to reach US$ 460.8 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
North American market for Ezetimibe is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ezetimibe is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ezetimibe include Merck, Teva, Zydus Pharmaceuticals, Amneal Pharmaceuticals, Alkem Laboratories, APOTEX, Sandoz, Glenmark Pharmaceuticals and Mylan Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ezetimibe, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ezetimibe.
Report Scope
The Ezetimibe market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ezetimibe market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ezetimibe manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Teva
Zydus Pharmaceuticals
Amneal Pharmaceuticals
Alkem Laboratories
APOTEX
Sandoz
Glenmark Pharmaceuticals
Mylan Pharmaceuticals
Aurobindo Pharma
Accord Healthcare
Segment by Type
5mg
10mg
20mg
40mg
80mg
Segment by Application
Adult
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ezetimibe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ezetimibe in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Ezetimibe Market Overview
1.1 Product Overview and Scope of Ezetimibe
1.2 Ezetimibe Segment by Type
1.2.1 Global Ezetimibe Market Value Comparison by Type (2024-2030)
1.2.2 5mg
1.2.3 10mg
1.2.4 20mg
1.2.5 40mg
1.2.6 80mg
1.3 Ezetimibe Segment by Application
1.3.1 Global Ezetimibe Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Children
1.4 Global Ezetimibe Market Size Estimates and Forecasts
1.4.1 Global Ezetimibe Revenue 2019-2030
1.4.2 Global Ezetimibe Sales 2019-2030
1.4.3 Global Ezetimibe Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ezetimibe Market Competition by Manufacturers
2.1 Global Ezetimibe Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ezetimibe Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ezetimibe Average Price by Manufacturers (2019-2024)
2.4 Global Ezetimibe Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ezetimibe, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ezetimibe, Product Type & Application
2.7 Ezetimibe Market Competitive Situation and Trends
2.7.1 Ezetimibe Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ezetimibe Players Market Share by Revenue
2.7.3 Global Ezetimibe Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ezetimibe Retrospective Market Scenario by Region
3.1 Global Ezetimibe Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ezetimibe Global Ezetimibe Sales by Region: 2019-2030
3.2.1 Global Ezetimibe Sales by Region: 2019-2024
3.2.2 Global Ezetimibe Sales by Region: 2025-2030
3.3 Global Ezetimibe Global Ezetimibe Revenue by Region: 2019-2030
3.3.1 Global Ezetimibe Revenue by Region: 2019-2024
3.3.2 Global Ezetimibe Revenue by Region: 2025-2030
3.4 North America Ezetimibe Market Facts & Figures by Country
3.4.1 North America Ezetimibe Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ezetimibe Sales by Country (2019-2030)
3.4.3 North America Ezetimibe Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ezetimibe Market Facts & Figures by Country
3.5.1 Europe Ezetimibe Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ezetimibe Sales by Country (2019-2030)
3.5.3 Europe Ezetimibe Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ezetimibe Market Facts & Figures by Country
3.6.1 Asia Pacific Ezetimibe Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ezetimibe Sales by Country (2019-2030)
3.6.3 Asia Pacific Ezetimibe Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ezetimibe Market Facts & Figures by Country
3.7.1 Latin America Ezetimibe Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ezetimibe Sales by Country (2019-2030)
3.7.3 Latin America Ezetimibe Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ezetimibe Market Facts & Figures by Country
3.8.1 Middle East and Africa Ezetimibe Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ezetimibe Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ezetimibe Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ezetimibe Sales by Type (2019-2030)
4.1.1 Global Ezetimibe Sales by Type (2019-2024)
4.1.2 Global Ezetimibe Sales by Type (2025-2030)
4.1.3 Global Ezetimibe Sales Market Share by Type (2019-2030)
4.2 Global Ezetimibe Revenue by Type (2019-2030)
4.2.1 Global Ezetimibe Revenue by Type (2019-2024)
4.2.2 Global Ezetimibe Revenue by Type (2025-2030)
4.2.3 Global Ezetimibe Revenue Market Share by Type (2019-2030)
4.3 Global Ezetimibe Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ezetimibe Sales by Application (2019-2030)
5.1.1 Global Ezetimibe Sales by Application (2019-2024)
5.1.2 Global Ezetimibe Sales by Application (2025-2030)
5.1.3 Global Ezetimibe Sales Market Share by Application (2019-2030)
5.2 Global Ezetimibe Revenue by Application (2019-2030)
5.2.1 Global Ezetimibe Revenue by Application (2019-2024)
5.2.2 Global Ezetimibe Revenue by Application (2025-2030)
5.2.3 Global Ezetimibe Revenue Market Share by Application (2019-2030)
5.3 Global Ezetimibe Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Ezetimibe Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Ezetimibe Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Ezetimibe Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Ezetimibe Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Zydus Pharmaceuticals
6.3.1 Zydus Pharmaceuticals Corporation Information
6.3.2 Zydus Pharmaceuticals Description and Business Overview
6.3.3 Zydus Pharmaceuticals Ezetimibe Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zydus Pharmaceuticals Ezetimibe Product Portfolio
6.3.5 Zydus Pharmaceuticals Recent Developments/Updates
6.4 Amneal Pharmaceuticals
6.4.1 Amneal Pharmaceuticals Corporation Information
6.4.2 Amneal Pharmaceuticals Description and Business Overview
6.4.3 Amneal Pharmaceuticals Ezetimibe Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amneal Pharmaceuticals Ezetimibe Product Portfolio
6.4.5 Amneal Pharmaceuticals Recent Developments/Updates
6.5 Alkem Laboratories
6.5.1 Alkem Laboratories Corporation Information
6.5.2 Alkem Laboratories Description and Business Overview
6.5.3 Alkem Laboratories Ezetimibe Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Alkem Laboratories Ezetimibe Product Portfolio
6.5.5 Alkem Laboratories Recent Developments/Updates
6.6 APOTEX
6.6.1 APOTEX Corporation Information
6.6.2 APOTEX Description and Business Overview
6.6.3 APOTEX Ezetimibe Sales, Revenue and Gross Margin (2019-2024)
6.6.4 APOTEX Ezetimibe Product Portfolio
6.6.5 APOTEX Recent Developments/Updates
6.7 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Ezetimibe Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz Ezetimibe Product Portfolio
6.7.5 Sandoz Recent Developments/Updates
6.8 Glenmark Pharmaceuticals
6.8.1 Glenmark Pharmaceuticals Corporation Information
6.8.2 Glenmark Pharmaceuticals Description and Business Overview
6.8.3 Glenmark Pharmaceuticals Ezetimibe Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Glenmark Pharmaceuticals Ezetimibe Product Portfolio
6.8.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.9 Mylan Pharmaceuticals
6.9.1 Mylan Pharmaceuticals Corporation Information
6.9.2 Mylan Pharmaceuticals Description and Business Overview
6.9.3 Mylan Pharmaceuticals Ezetimibe Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Pharmaceuticals Ezetimibe Product Portfolio
6.9.5 Mylan Pharmaceuticals Recent Developments/Updates
6.10 Aurobindo Pharma
6.10.1 Aurobindo Pharma Corporation Information
6.10.2 Aurobindo Pharma Description and Business Overview
6.10.3 Aurobindo Pharma Ezetimibe Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Aurobindo Pharma Ezetimibe Product Portfolio
6.10.5 Aurobindo Pharma Recent Developments/Updates
6.11 Accord Healthcare
6.11.1 Accord Healthcare Corporation Information
6.11.2 Accord Healthcare Ezetimibe Description and Business Overview
6.11.3 Accord Healthcare Ezetimibe Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Accord Healthcare Ezetimibe Product Portfolio
6.11.5 Accord Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ezetimibe Industry Chain Analysis
7.2 Ezetimibe Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ezetimibe Production Mode & Process
7.4 Ezetimibe Sales and Marketing
7.4.1 Ezetimibe Sales Channels
7.4.2 Ezetimibe Distributors
7.5 Ezetimibe Customers
8 Ezetimibe Market Dynamics
8.1 Ezetimibe Industry Trends
8.2 Ezetimibe Market Drivers
8.3 Ezetimibe Market Challenges
8.4 Ezetimibe Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
